MarketCap
Facebook
X
TelegramQuarterly report 2025-Q4
added 02-10-2026
Sonoma Pharmaceuticals ROCE Ratio 2011-2026 | SNOA
Annual ROCE Ratio Sonoma Pharmaceuticals
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -84.11 | -76.6 | -57.29 | -67.69 | -64.31 | -68.8 | -103.69 | -88.99 | -58.52 | -99.02 | -53.41 | -45.78 | -45.36 | -209.36 | -176.63 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -45.36 | -209.36 | -86.64 |
Quarterly ROCE Ratio Sonoma Pharmaceuticals
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -76.82 | -78.24 | -85.22 | -60.63 | -73.24 | -64.68 | -70.09 | -51.02 | -84.01 | -104.39 | -93.52 | -54.15 | -62.72 | -38.31 | -52.57 | -73.69 | -74.81 | -67.36 | -43.81 | -0.78 | -7.01 | -15.78 | -23.42 | -36.58 | -45.39 | -53.12 | -61.97 | -74.86 | -82.27 | -87.1 | -87.16 | -58.31 | -73.9 | -67.05 | -215.99 | -266.02 | -311.96 | -342.31 | -278.96 | -186.64 | -211.54 | -190.5 | -124.68 | -85.16 | -130.67 | -151.29 | -368.22 | -391.49 | -413.23 | -389.46 | 262.53 | -7.76 | -1451.93 | -2874.36 | 405.97 | 1549.53 | -1444.17 | 3677.94 | -684.24 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 3677.94 | -2874.36 | -113.7 |
ROCE Ratio of other stocks in the Drug manufacturers industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Assertio Holdings
ASRT
|
-22.92 | $ 18.03 | 0.06 % | $ 115 M |  USA |
 |
Agile Therapeutics
AGRX
|
121.85 | - | 10.11 % | $ 58.2 M | USA |
 |
AcelRx Pharmaceuticals
ACRX
|
-79.15 | - | 7.5 % | $ 6.35 M | USA |
 |
Adamis Pharmaceuticals Corporation
ADMP
|
3101.1 | - | 0.86 % | $ 117 M | USA |
 |
Aerie Pharmaceuticals
AERI
|
267.43 | - | - | $ 754 M | USA |
 |
Catalent
CTLT
|
-20.78 | - | - | $ 11.5 B | USA |
 |
DURECT Corporation
DRRX
|
-249.5 | - | - | $ 50.1 M | USA |
 |
Alimera Sciences
ALIM
|
-4.18 | - | - | $ 142 M | USA |
 |
Athenex
ATNX
|
1076.15 | - | -23.39 % | $ 1.76 M | USA |
 |
Eagle Pharmaceuticals
EGRX
|
34.66 | - | -39.89 % | $ 27.7 M | USA |
 |
Endo International plc
ENDP
|
7.34 | - | - | $ 28.9 M |  Irlanda |
 |
Avadel Pharmaceuticals plc
AVDL
|
-57.41 | - | - | $ 2.06 B |  France |
 |
Evoke Pharma
EVOK
|
-184.26 | - | - | $ 36.6 M | USA |
 |
Cumberland Pharmaceuticals
CPIX
|
-8.06 | $ 3.26 | 5.5 % | $ 45.8 M | USA |
 |
Cronos Group
CRON
|
-10.43 | $ 2.57 | -0.39 % | $ 1.33 B |  Canada |
 |
Calliditas Therapeutics AB (publ)
CALT
|
-39.6 | - | -0.1 % | $ 2.03 B |  Schweden |
 |
HEXO Corp.
HEXO
|
-85.61 | - | 2.45 % | $ 38.1 M | Canada |
 |
Bausch Health Companies
BHC
|
-94.23 | $ 5.64 | 0.45 % | $ 2.06 B | Canada |
 |
Harrow Health
HROW
|
58.18 | $ 36.64 | 1.98 % | $ 1.35 B | USA |
 |
Aurora Cannabis
ACB
|
-23.09 | $ 3.36 | -2.04 % | $ 86.3 M | Canada |
 |
Canopy Growth Corporation
CGC
|
-24.04 | $ 1.03 | -1.43 % | $ 111 M | Canada |
 |
OrganiGram Holdings
OGI
|
-35.84 | $ 1.4 | -0.36 % | $ 402 M | Canada |
 |
Neoleukin Therapeutics
NLTX
|
-39.01 | - | - | $ 193 M | Canada |
 |
Jupiter Wellness
JUPW
|
-116.71 | - | - | $ 33.6 M | USA |
 |
Relmada Therapeutics
RLMD
|
-68.31 | $ 7.37 | 1.1 % | $ 291 M | USA |
 |
Lannett Company
LCI
|
70.21 | - | 1.15 % | $ 7.11 M | USA |
 |
Evolus
EOLS
|
141.36 | $ 4.35 | 1.76 % | $ 280 M | USA |
 |
Emergent BioSolutions
EBS
|
-111.87 | $ 8.0 | 0.5 % | $ 410 M | USA |
 |
Sundial Growers
SNDL
|
-68.48 | $ 1.37 | -3.87 % | $ 3.37 M | Canada |
 |
Tilray
TLRY
|
-41.31 | $ 6.49 | -1.29 % | $ 4.01 B | Canada |
 |
Organogenesis Holdings
ORGO
|
-0.49 | $ 2.37 | -0.35 % | $ 312 M | USA |
 |
Pacira BioSciences
PCRX
|
-9.43 | $ 24.3 | 2.14 % | $ 1.12 B | USA |
 |
PetIQ
PETQ
|
5.46 | - | 1.64 % | $ 400 M | USA |
 |
Veru
VERU
|
-114.23 | $ 2.42 | 1.68 % | $ 326 M | USA |
 |
Viatris
VTRS
|
3.74 | $ 13.53 | 0.45 % | $ 16.2 B | USA |
 |
ProPhase Labs
PRPH
|
32.97 | - | - | $ 5.07 M | USA |
 |
cbdMD
YCBD
|
-235.96 | $ 0.7 | 4.36 % | $ 3.02 M | USA |
 |
Radius Health
RDUS
|
21.53 | - | - | $ 1.42 B | USA |
 |
Recro Pharma
REPH
|
-6.09 | - | -4.76 % | $ 65.3 M | USA |
 |
OptiNose
OPTN
|
26.27 | - | - | $ 1.08 B | USA |
 |
SCYNEXIS
SCYX
|
-32.55 | $ 1.02 | 2.0 % | $ 50.9 M | USA |
 |
PLx Pharma
PLXP
|
-114.37 | - | -27.8 % | $ 2.56 M | USA |
 |
Solid Biosciences
SLDB
|
-90.02 | $ 7.92 | -1.25 % | $ 693 M | USA |
 |
Zomedica Corp.
ZOM
|
-73.1 | - | -0.21 % | $ 98 M | USA |
 |
Zynerba Pharmaceuticals
ZYNE
|
-76.25 | - | - | $ 55.5 M | USA |
 |
Rockwell Medical
RMTI
|
-12.68 | $ 0.91 | 0.02 % | $ 32.7 M | USA |
 |
Tricida
TCDA
|
-70162.39 | - | - | $ 3.25 M | USA |
 |
China Pharma Holdings
CPHI
|
-14.24 | $ 0.65 | 3.14 % | $ 2.79 M |  China |
 |
TherapeuticsMD
TXMD
|
-16.33 | $ 2.03 | -1.93 % | $ 23.5 M | USA |